<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02620917</url>
  </required_header>
  <id_info>
    <org_study_id>3506/AO/15</org_study_id>
    <nct_id>NCT02620917</nct_id>
  </id_info>
  <brief_title>Continuos Subcutaneous Insulin Infusion in Italy</brief_title>
  <acronym>IMITA2</acronym>
  <official_title>Survey on Continuos Subcutaneous Insulin Infusion in Italy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Padova</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Padova</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is an observational, multicenter, cross sectional study, collecting clinical and
      metabolic informations about patients treated with CSII in Italy.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The aim of the study is to collect clinical and metabolic characteristics of patient treated
      with CSII in Italy.

      Data will be collected through a questionnaire sent by e-mail to CSII experienced Diabetes
      Centers ( both adult and pediatric patients) . The questionnaire assessed: (1) number of
      CSII-treated patients; (2) patients and pump characteristics; (3) structure and organization
      of Diabetes Centers providing CSII therapy; (4) metabolic control.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">November 1, 2015</start_date>
  <completion_date type="Actual">December 1, 2017</completion_date>
  <primary_completion_date type="Actual">December 1, 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Efficacy Assessed by Median of HbA1c,</measure>
    <time_frame>1 year</time_frame>
    <description>median of HbA1c measured in the last year</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Patients With Severe Hypoglycemia</measure>
    <time_frame>1year</time_frame>
    <description>Number of patients reporting severe hypoglycemia (requiring assistance by an other person) in the last year</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of Patients With Glycated Hemoglobin on Target</measure>
    <time_frame>1 year</time_frame>
    <description>number of patients who achieved HbA1c target (&lt; 7,5% in patients &lt; 18 years old; &lt;7% in adult patients);</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of Patients With HbA1c on Target Using Advanced Pump's Functions, CGM and CHO Counting</measure>
    <time_frame>1 year</time_frame>
    <description>number of patients adults with HbA1c &lt;7,0% using advanced pump's functions, CGM and CHO counting number of paediatrics patients with HbA1c &lt; 7.5% using advanced pump's functions, CGM and CHO counting</description>
  </secondary_outcome>
  <enrollment type="Actual">6623</enrollment>
  <condition>Type 1 Diabetes</condition>
  <eligibility>
    <study_pop>
      <textblock>
        we will evaluate allItalian patients treated with insulin pump
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  all patients treated with CSIIin Italy

        Exclusion Criteria:

          -  none
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Daniela Bruttomesso, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Padova</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Padova</name>
      <address>
        <city>Padova</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>November 23, 2015</study_first_submitted>
  <study_first_submitted_qc>November 30, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 3, 2015</study_first_posted>
  <results_first_submitted>January 12, 2018</results_first_submitted>
  <results_first_submitted_qc>March 26, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">April 8, 2020</results_first_posted>
  <last_update_submitted>March 26, 2020</last_update_submitted>
  <last_update_submitted_qc>March 26, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">April 8, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Padova</investigator_affiliation>
    <investigator_full_name>Daniela Bruttomesso</investigator_full_name>
    <investigator_title>MD medical doctor, PhD</investigator_title>
  </responsible_party>
  <keyword>type 1 diabetes</keyword>
  <keyword>CSII</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus, Type 1</mesh_term>
  </condition_browse>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>March 30, 2015</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/17/NCT02620917/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Continuous Subcutaneous Insulin Infusion (CSII) Treatment</title>
          <description>Patients who received Continuous subcutaneous insulin infusion (CSII) treatment in Italy</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="6623"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="6623"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>CSII Treatment</title>
          <description>Patients who received CSII treatment in Italy</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="6623"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="37" lower_limit="22" upper_limit="49"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="3827"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2796"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="6623"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Italy</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="6623"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Efficacy Assessed by Median of HbA1c,</title>
        <description>median of HbA1c measured in the last year</description>
        <time_frame>1 year</time_frame>
        <group_list>
          <group group_id="O1">
            <title>CSII Treatment</title>
            <description>Patients who received CSII treatment in Italy</description>
          </group>
        </group_list>
        <measure>
          <title>Efficacy Assessed by Median of HbA1c,</title>
          <description>median of HbA1c measured in the last year</description>
          <units>mmol/mol</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="6623"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="60" lower_limit="53" upper_limit="67"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Patients With Severe Hypoglycemia</title>
        <description>Number of patients reporting severe hypoglycemia (requiring assistance by an other person) in the last year</description>
        <time_frame>1year</time_frame>
        <group_list>
          <group group_id="O1">
            <title>CSII Treatment</title>
            <description>Patients who received CSII treatment in Italy</description>
          </group>
        </group_list>
        <measure>
          <title>Patients With Severe Hypoglycemia</title>
          <description>Number of patients reporting severe hypoglycemia (requiring assistance by an other person) in the last year</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="6623"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="331"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Number of Patients With Glycated Hemoglobin on Target</title>
        <description>number of patients who achieved HbA1c target (&lt; 7,5% in patients &lt; 18 years old; &lt;7% in adult patients);</description>
        <time_frame>1 year</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Adults on CSII Treatment</title>
            <description>Patients who received CSII treatment in Italy ( = or &gt; 18 YEARS OLD)</description>
          </group>
          <group group_id="O2">
            <title>Paediatric Patients on CSII Treatment</title>
            <description>Patients &lt; 18 years old ON CSII treatment</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Patients With Glycated Hemoglobin on Target</title>
          <description>number of patients who achieved HbA1c target (&lt; 7,5% in patients &lt; 18 years old; &lt;7% in adult patients);</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="5598"/>
                <count group_id="O2" value="1025"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1288"/>
                    <measurement group_id="O2" value="445"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Patients With HbA1c on Target Using Advanced Pump's Functions, CGM and CHO Counting</title>
        <description>number of patients adults with HbA1c &lt;7,0% using advanced pump's functions, CGM and CHO counting number of paediatrics patients with HbA1c &lt; 7.5% using advanced pump's functions, CGM and CHO counting</description>
        <time_frame>1 year</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Adults on CSII Treatment</title>
            <description>Patients who received CSII treatment in Italy ( = or &gt; 18 YEARS OLD)</description>
          </group>
          <group group_id="O2">
            <title>Paediatric Patients on CSII Treatment</title>
            <description>Patients &lt; 18 years old ON CSII treatment</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Patients With HbA1c on Target Using Advanced Pump's Functions, CGM and CHO Counting</title>
          <description>number of patients adults with HbA1c &lt;7,0% using advanced pump's functions, CGM and CHO counting number of paediatrics patients with HbA1c &lt; 7.5% using advanced pump's functions, CGM and CHO counting</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="5598"/>
                <count group_id="O2" value="1025"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1713"/>
                    <measurement group_id="O2" value="515"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>time of observations= 1 years.</time_frame>
      <desc>no adverse events (study correlated and not study correlated) occurred</desc>
      <group_list>
        <group group_id="E1">
          <title>CSII Treatment</title>
          <description>Patients who received CSII treatment in Italy</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6223"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6223"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>1</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6223"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Daniela Bruttomesso</name_or_title>
      <organization>University of Padova</organization>
      <phone>0039 049/8212183</phone>
      <email>daniela.bruttomesso@unipd.it</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

